SEEKING ALPHA‘s Wall Street Breakfast just hit the wires:
Two drugmakers at the forefront of the industry’s efforts to fight the novel coronavirus are exploring a combined future. AstraZeneca (NYSE:AZN), co-developer of one of the fastest-moving experimental coronavirus vaccines, has made a preliminary approach to Gilead Sciences (NASDAQ:GILD), the only company to have received FDA emergency authorization for its COVID-19 treatment remdesivir. Formal talks are not yet underway, but if combined, …
The post SA’s Wall Street Breakfast: Biggest healthcare deal on record? appeared first on The Loadstar.
Source: The Loadstar